Doctor profile · Federal record
Dr. CESAR ALFARO CRUZ, MD
Ophthalmology Physician (CMS: OPHTHALMOLOGY) · Ophthalmology Physician · BRIDGEWATER, NJ
- NPI 1740712637
- Accepts Medicare
- MIPS 90.9 / 100 · 2023
- 9 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
1200 ROUTE 22
BRIDGEWATER, NJ 088072943
(908) 218-4303
fax (908) 218-4307 - Additional location
-
800 W State St Ste 301
Doylestown, PA 189015843
(215) 230-8599
fax (609) 896-2982 - Mailing address
-
420 MOUNTAIN AVE FL 4
NEW PROVIDENCE, NJ 079742736
Credentials & registration
- NPI registered
- March 2017 — 9 yrs on file
- Profile last updated
- February 4, 2026
- Year of graduation
- 2017 — 9 yrs since
- Specialty taxonomy
- 207W00000X — NUCC code
- State licenses (2)
- New Jersey #25MA11731400 · Pennsylvania #MD482952
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1740712637. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,846
Distinct HCPCS
10
Medicare allowed
$420,816
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J2777 |
Injection, faricimab-svoa, 0.1 mg | 1,080 | 11 | $36 | |
92134 |
Imaging of retina | 360 | 300 | $44 | |
92014 |
Established patient complete exam of visual system | 270 | 233 | $140 | |
67028 |
Injection of drug into eye | 193 | 133 | $131 | |
92202 |
Extended exam of the back part of the eye with optic nerve drawing | 189 | 166 | $16 | |
Q5128 |
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 175 | 23 | $269 | |
J0178 |
Injection, aflibercept, 1 mg | 146 | 48 | $843 | |
92004 |
New patient complete exam of visual system | 114 | 114 | $165 | |
92201 |
Extended exam of the back part of the eye with retinal drawing | 86 | 74 | $26 | |
92250 |
Photography of the retina | 65 | 62 | $40 |
In context: peer comparison
Among 2 peers in this city , average services per provider: 161. This provider delivers 18× the peer median.Open Payments
Industry payments received
All-time total
$533
Transactions
17
Manufacturers
6
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 8 | $245.47 | |
| Astellas Pharma US Inc | 1 | $124.99 | |
| ABBVIE INC. | 3 | $62.18 | |
| Alimera Sciences, Inc. | 3 | $48.33 | |
| Genentech USA, Inc. | 1 | $26.64 | |
| Bausch & Lomb Americas Inc. | 1 | $25.37 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
67
Patients
30
Total drug cost
$7,336
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisolone Acetate | Generic | 42 | 30 | $2,738 |
| Brimonidine Tartrate | Generic | 14 | 0 | $718 |
| Prolensa (Bromfenac Sodium) | Brand | 11 | 0 | $3,880 |